Putra Santoso, Syafruddin Ilyas, Yurnadi Hanafi Midoen, Alfi Yuniarti
Diabetes mellitus is profoundly associated with various detrimental outcomes including sexual dysfunction and infertility in males. On the other hand, a medicinal plant namely Vitis gracilis Wall (Vitaceae) has been used as a traditional medicine to enhance vitality. This present study aimed to investigate the protective effect of V. gracilis leaf decoction against diabetes-induced sexual dysfunction and testicle histopathology in adult male mice. The experiment was composed of five different groups namely the control (non-diabetic) group, the diabetes group (without any treatments), and the diabetes treated with V. gracilis decoction at the doses of 25, 50, and 100 g/L, respectively. In addition, the phytochemical constituents of leaf decoction were determined by using Ultra performance-liquid chromatography-mass spectroscopy (UPLC-MS). Our data demonstrated that, despite failing to improve blood glucose profile and body weight, V. gracilis leaf decoction sustained intense sexual behaviors including face and genital kissing, genital licking, and mount toward estrous females. Moreover, lower doses of decoction (25 and 50 g/L) attenuated the diabetes-induced reduction of testis weight and precluded malondialdehyde accumulation in the testicle tissue. The decoction at the lower doses also ameliorated histopathological alterations in the testis, particularly the wall thickness of tubulus seminiferous and the number of necrotic cells. V. gracilis decoction also improved hematological values including hemoglobin, red blood cell count and hematocrit level. In addition, UPLC-MS analysis revealed a total of 26 phytochemical compounds with seven predominant substances. In conclusion, leaf decoction of V. gracilis, particularly at lower doses but not at a higher dose, exerted a protective effect on sexual vitality, testicle tissue, and hematological value under diabetic condition. The beneficial effects of V. gracilis decoction might be associated with its various bioactive compounds. Therefore, V. gracilis leaves may be a future candidate as a potent natural drug for male sexual vitality and testicle protection against diabetes.
{"title":"Protective Effect of Vitis gracilis Wall (Vitaceae) Leaf Decoction on Sexual Vitality and Testis of Alloxan-Induced Diabetic Mice","authors":"Putra Santoso, Syafruddin Ilyas, Yurnadi Hanafi Midoen, Alfi Yuniarti","doi":"10.18502/tim.v8i3.13711","DOIUrl":"https://doi.org/10.18502/tim.v8i3.13711","url":null,"abstract":"Diabetes mellitus is profoundly associated with various detrimental outcomes including sexual dysfunction and infertility in males. On the other hand, a medicinal plant namely Vitis gracilis Wall (Vitaceae) has been used as a traditional medicine to enhance vitality. This present study aimed to investigate the protective effect of V. gracilis leaf decoction against diabetes-induced sexual dysfunction and testicle histopathology in adult male mice. The experiment was composed of five different groups namely the control (non-diabetic) group, the diabetes group (without any treatments), and the diabetes treated with V. gracilis decoction at the doses of 25, 50, and 100 g/L, respectively. In addition, the phytochemical constituents of leaf decoction were determined by using Ultra performance-liquid chromatography-mass spectroscopy (UPLC-MS). Our data demonstrated that, despite failing to improve blood glucose profile and body weight, V. gracilis leaf decoction sustained intense sexual behaviors including face and genital kissing, genital licking, and mount toward estrous females. Moreover, lower doses of decoction (25 and 50 g/L) attenuated the diabetes-induced reduction of testis weight and precluded malondialdehyde accumulation in the testicle tissue. The decoction at the lower doses also ameliorated histopathological alterations in the testis, particularly the wall thickness of tubulus seminiferous and the number of necrotic cells. V. gracilis decoction also improved hematological values including hemoglobin, red blood cell count and hematocrit level. In addition, UPLC-MS analysis revealed a total of 26 phytochemical compounds with seven predominant substances. In conclusion, leaf decoction of V. gracilis, particularly at lower doses but not at a higher dose, exerted a protective effect on sexual vitality, testicle tissue, and hematological value under diabetic condition. The beneficial effects of V. gracilis decoction might be associated with its various bioactive compounds. Therefore, V. gracilis leaves may be a future candidate as a potent natural drug for male sexual vitality and testicle protection against diabetes. 
","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135199675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammad Mehdi Gravandi, Seyede Zahra Hosseini, Seyede Darya Alavi, Seyed Mohammad Reza Jafari, Mohsen Zhaleh, Mohammad Hosein Farzaei
Inflammatory bowel disease (IBD) has two subtypes called ulcerative colitis (UC) and Crohn's disease (CD). They have the same tissue damage processes; however, differ in the initial procedures and immune regulatory aberrations. Tumor necrosis factor-alpha (TNF-α) appears to have an important function and a key pathogenic role in CD and UC. In this paper, we evaluated the protective impact of the extract of Ailanthus altissima (Mill.) Swingle (tree of heaven), Simaroubaceae, in acetic acid-induced UC. Ferric-reducing capacity of plant extract, total phenols, and total flavonoid contents were measured in A. altissima ethanolic extract. Thirty male rats were randomly divided into six groups including control, normal, mesalazine 300 mg/kg (positive control) and 3 treatment groups with doses of 50, 100, and 200 mg/kg for 7 days. Except for the normal group, all animals received 2 mL of 4% acetic acid infusion into the large intestine. Upon 48 h after the last gavage, the animals were euthanized. Acetic acid intracolonic administration resulted in a severe acute inflammation in the colonic tissue, which was improved by A. altissima extract at all examined doses in both microscopic and macroscopic aspects. In comparison to the control, TNF-α was considerably lower in the mesalazine and 200 mg/kg A. altissima extract groups. Conclusively, the valuable effects of the extract in the treatment of UC were confirmed by TNF-α levels, histological data, and macroscopic observations, especially at 200 mg/kg dosage. Future studies are recommended to further clarify the action mechanisms of this plant.
{"title":"Evaluating the Protective Effect of Ailanthus altissima (Mill.) Swingle in a Rat Model of Acetic Acid-Induced Ulcerative Colitis","authors":"Mohammad Mehdi Gravandi, Seyede Zahra Hosseini, Seyede Darya Alavi, Seyed Mohammad Reza Jafari, Mohsen Zhaleh, Mohammad Hosein Farzaei","doi":"10.18502/tim.v8i3.13708","DOIUrl":"https://doi.org/10.18502/tim.v8i3.13708","url":null,"abstract":"Inflammatory bowel disease (IBD) has two subtypes called ulcerative colitis (UC) and Crohn's disease (CD). They have the same tissue damage processes; however, differ in the initial procedures and immune regulatory aberrations. Tumor necrosis factor-alpha (TNF-α) appears to have an important function and a key pathogenic role in CD and UC. In this paper, we evaluated the protective impact of the extract of Ailanthus altissima (Mill.) Swingle (tree of heaven), Simaroubaceae, in acetic acid-induced UC. Ferric-reducing capacity of plant extract, total phenols, and total flavonoid contents were measured in A. altissima ethanolic extract. Thirty male rats were randomly divided into six groups including control, normal, mesalazine 300 mg/kg (positive control) and 3 treatment groups with doses of 50, 100, and 200 mg/kg for 7 days. Except for the normal group, all animals received 2 mL of 4% acetic acid infusion into the large intestine. Upon 48 h after the last gavage, the animals were euthanized. Acetic acid intracolonic administration resulted in a severe acute inflammation in the colonic tissue, which was improved by A. altissima extract at all examined doses in both microscopic and macroscopic aspects. In comparison to the control, TNF-α was considerably lower in the mesalazine and 200 mg/kg A. altissima extract groups. Conclusively, the valuable effects of the extract in the treatment of UC were confirmed by TNF-α levels, histological data, and macroscopic observations, especially at 200 mg/kg dosage. Future studies are recommended to further clarify the action mechanisms of this plant.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135246083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Soghra Mohammadi, Mohsen Masoodi, Mohammad Sabzikarian, Atefeh Talebi, Marjan Mokhtare, Abolfazl Akbari, Amirhossein Faghihi Kashani
Due to the lack of favorable response to synthetic drugs, the tendency to use traditional medicine to treat inflammatory bowel disease has risen. We aimed to assess the effect of Cichorium intybus L., Trigonella foenum-graecum L., and Foeniculum vulgare L. on the control of recurrent ulcerative colitis (UC) symptoms. This randomized clinical trial was performed on 60 patients suffering from mild-to-moderate UC. Patients were randomly assigned to control and intervention groups. Patients in both groups were treated with a standard dose of oral mesalazine (3 g daily) for eight weeks. In addition, the intervention group was given a mixture of 200 mg C. intybus, 350 mg T. foenum-graecum, and 1.5 mg F. vulgare (three times a day). The disease activity was evaluated before and 60 days after the intervention using a simple clinical colitis activity index (SCCAI). The baseline mean SCCAI score was similar in both groups. Although the SCCAI score significantly reduced in both groups 60 days after the initial assessment, this reduction was significantly higher in the group receiving the herbal combination than in the control group. The intervention-related side effects, such as bloating and dyspepsia, were well tolerated. The use of C. intybus, T. foenum-graecum, and F. vulgare can effectively control UC symptoms and thus, can be used as an effective and safe medication for treating UC.
{"title":"The Efficacy of Cichorium intybus L., Trigonella foenum-graecum L. and Foeniculum vulgare Mill. in Improvement of Ulcerative Colitis Symptoms: A Randomized Clinical Trial","authors":"Soghra Mohammadi, Mohsen Masoodi, Mohammad Sabzikarian, Atefeh Talebi, Marjan Mokhtare, Abolfazl Akbari, Amirhossein Faghihi Kashani","doi":"10.18502/tim.v8i3.13712","DOIUrl":"https://doi.org/10.18502/tim.v8i3.13712","url":null,"abstract":"Due to the lack of favorable response to synthetic drugs, the tendency to use traditional medicine to treat inflammatory bowel disease has risen. We aimed to assess the effect of Cichorium intybus L., Trigonella foenum-graecum L., and Foeniculum vulgare L. on the control of recurrent ulcerative colitis (UC) symptoms. This randomized clinical trial was performed on 60 patients suffering from mild-to-moderate UC. Patients were randomly assigned to control and intervention groups. Patients in both groups were treated with a standard dose of oral mesalazine (3 g daily) for eight weeks. In addition, the intervention group was given a mixture of 200 mg C. intybus, 350 mg T. foenum-graecum, and 1.5 mg F. vulgare (three times a day). The disease activity was evaluated before and 60 days after the intervention using a simple clinical colitis activity index (SCCAI). The baseline mean SCCAI score was similar in both groups. Although the SCCAI score significantly reduced in both groups 60 days after the initial assessment, this reduction was significantly higher in the group receiving the herbal combination than in the control group. The intervention-related side effects, such as bloating and dyspepsia, were well tolerated. The use of C. intybus, T. foenum-graecum, and F. vulgare can effectively control UC symptoms and thus, can be used as an effective and safe medication for treating UC.
","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":"72 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135245762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In Iranian traditional medicine, donkey dung, known as "Anbar-Nesara" is used for its antimicrobial and antiallergic properties. Incorrect medical beliefs can lead to the incorrect use of complementary medicine and the creation of unnecessary harmful effects. Although there have been many reports about the traditional medical benefits and the use of Anbar-Nesara, we describe a woman with severe wound infection following surgical and administration of Anbar-Nesara smoke.
{"title":"Improper Use of Traditional Medicine “Anbar Nesara” for Wound Infection: A Case Report","authors":"Marzieh Vahid Dastjerdi, Akram Ghahghaei-Nezamabadi, Afsaneh Tehranian, Parisa Mansouri, Ladan Hosseini","doi":"10.18502/tim.v8i3.13713","DOIUrl":"https://doi.org/10.18502/tim.v8i3.13713","url":null,"abstract":"In Iranian traditional medicine, donkey dung, known as \"Anbar-Nesara\" is used for its antimicrobial and antiallergic properties. Incorrect medical beliefs can lead to the incorrect use of complementary medicine and the creation of unnecessary harmful effects. Although there have been many reports about the traditional medical benefits and the use of Anbar-Nesara, we describe a woman with severe wound infection following surgical and administration of Anbar-Nesara smoke.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135246412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seddigheh Meghdadi, Amirsaeed Hosseini, Mohammad Kamalinejad, Mohammad Yousofpour
Chronic kidney disease (CKD) is recognized as a major global health problem, which is associated with numerous complications. This disease is characterized by kidney dysfunction and a reduced glomerular filtration rate. Among the main causes of this disease, we can refer to hypertension, diabetes, autoimmune diseases, and polycystic kidney disease. Despite the recent treatments, we are witnessing a rise in the cases of disease progression and the need for renal replacement therapy. The present study aimed to assess the causes and symptoms, as well as prevention and treatment options for Hozal-e-Kolye (kidney atrophy) in Persian medical texts and compare it with CKD. To conduct this study, the terms related to "Hozal-e-Kolye" were searched in reliable and available books of Persian medicine such as Al-Qanoon fi al-Tibb, Sharh-ol-asbab va al alamat, Zakhire -e kharazmshahi, Teb-e-Akbari and other resources. To examine the CKD, all reliable medical books, such as Harrison and Brenner, as well as PubMed, Science direct, and Scopus databases were used. Following that, a comparison was made between the extracted data on Hozal-e-Kolye and those about CKD. According to the results of this study, common points were seen between the causes and symptoms of Hozal-e-Kolye and chronic kidney disease. In Persian medicine, the treatment of Hozal-e-Kolye includes removing the causes of the disease, and then performing treatments to hydrate kidneys. These treatments can be used in CKD patients, based on the similarities between these two diseases. Considering the similarities in the causes and symptoms of Hozal-e-Kolye and CKD, these two diseases can be deemed close in nature, and accordingly, research ideas can be designed and implemented to prevent and help treat CKD.
慢性肾脏疾病(CKD)被认为是一个主要的全球性健康问题，它与许多并发症有关。这种疾病的特点是肾功能不全和肾小球滤过率降低。在这种疾病的主要原因中，我们可以参考高血压，糖尿病，自身免疫性疾病和多囊肾病。尽管最近进行了治疗，但我们看到疾病进展的病例有所增加，需要肾脏替代治疗。本研究旨在评估波斯医学文献中Hozal-e-Kolye(肾萎缩)的病因和症状，以及预防和治疗方案，并将其与CKD进行比较。为了进行这项研究，在可靠和可用的波斯医学书籍中搜索了与“Hozal-e-Kolye”相关的术语，如al- qanoon fi al- tibb、Sharh-ol-asbab va al alamat、Zakhire -e kharazmshahi、Teb-e-Akbari和其他资源。为了检查CKD，使用了所有可靠的医学书籍，如Harrison和Brenner，以及PubMed, Science direct和Scopus数据库。随后，将提取的Hozal-e-Kolye数据与CKD数据进行比较。根据这项研究的结果，在Hozal-e-Kolye和慢性肾脏疾病的病因和症状之间发现了共同点。在波斯医学中，治疗Hozal-e-Kolye包括消除疾病的原因，然后进行肾脏补水治疗。基于这两种疾病之间的相似性，这些治疗方法可用于CKD患者。考虑到Hozal-e-Kolye和CKD的病因和症状相似，可以认为这两种疾病在本质上是接近的，因此可以设计和实施研究思路来预防和帮助治疗CKD。
{"title":"Chronic Kidney Disease and Its Comparison with Hozal-e-Kolye in Persian Medicine","authors":"Seddigheh Meghdadi, Amirsaeed Hosseini, Mohammad Kamalinejad, Mohammad Yousofpour","doi":"10.18502/tim.v8i3.13715","DOIUrl":"https://doi.org/10.18502/tim.v8i3.13715","url":null,"abstract":"Chronic kidney disease (CKD) is recognized as a major global health problem, which is associated with numerous complications. This disease is characterized by kidney dysfunction and a reduced glomerular filtration rate. Among the main causes of this disease, we can refer to hypertension, diabetes, autoimmune diseases, and polycystic kidney disease. Despite the recent treatments, we are witnessing a rise in the cases of disease progression and the need for renal replacement therapy. The present study aimed to assess the causes and symptoms, as well as prevention and treatment options for Hozal-e-Kolye (kidney atrophy) in Persian medical texts and compare it with CKD. To conduct this study, the terms related to \"Hozal-e-Kolye\" were searched in reliable and available books of Persian medicine such as Al-Qanoon fi al-Tibb, Sharh-ol-asbab va al alamat, Zakhire -e kharazmshahi, Teb-e-Akbari and other resources. To examine the CKD, all reliable medical books, such as Harrison and Brenner, as well as PubMed, Science direct, and Scopus databases were used. Following that, a comparison was made between the extracted data on Hozal-e-Kolye and those about CKD. According to the results of this study, common points were seen between the causes and symptoms of Hozal-e-Kolye and chronic kidney disease. In Persian medicine, the treatment of Hozal-e-Kolye includes removing the causes of the disease, and then performing treatments to hydrate kidneys. These treatments can be used in CKD patients, based on the similarities between these two diseases. Considering the similarities in the causes and symptoms of Hozal-e-Kolye and CKD, these two diseases can be deemed close in nature, and accordingly, research ideas can be designed and implemented to prevent and help treat CKD.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135246554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Abbassian, A. Massoud, M. Naseri, M. Kamalinejad, Parvaneh Mohseni-Moghaddam, F. Emadi, A. Zargaran
Wide range of acute and chronic inflammatory ailments, side effects of their available therapies and incomplete treatment of such patients push the researches to find new and more effective drugs. To reach this aim, in the current study, we evaluate Urtica pilulifera L. (family Urticaceae) as an introduced traditional herb for treatment of inflammation in Persian Medicine (PM). In an animal study, Anti-inflammatory effects of U. pilulifera were assessed in formalin-induced hind paw edema in rats. Sodium salicylate (300 mg/kg, i.p., SS) injection was used as a positive control drug and compared with methanolic extract of U. pilulifera (20 mg/kg; i.p.) (MUP), three different doses of aqueous extract of U. pilulifera (20, 40 and 80 mg/kg; i.p.) (AUP) and a group of distilled water (6 mL/kg; i.p.). As acute anti-inflammatory effect, AUP in doses 40 and 80 mg/kg decreased edema significantly (p<0.05). In chronic anti-inflammatory response, results indicated that all AUP doses had anti-inflammatory effects (p <0.05) with no significant difference with SS group. In conclusion, AUP had anti-inflammatory effects on both acute and chronic edema; while MUP was only effective in chronic inflammation.
{"title":"Anti –Inflammatory Effect of Methanolic and Aqueous Extracts of Urtica pilulifera L. Seed in Rats","authors":"A. Abbassian, A. Massoud, M. Naseri, M. Kamalinejad, Parvaneh Mohseni-Moghaddam, F. Emadi, A. Zargaran","doi":"10.18502/tim.v8i2.13080","DOIUrl":"https://doi.org/10.18502/tim.v8i2.13080","url":null,"abstract":"Wide range of acute and chronic inflammatory ailments, side effects of their available therapies and incomplete treatment of such patients push the researches to find new and more effective drugs. To reach this aim, in the current study, we evaluate Urtica pilulifera L. (family Urticaceae) as an introduced traditional herb for treatment of inflammation in Persian Medicine (PM). In an animal study, Anti-inflammatory effects of U. pilulifera were assessed in formalin-induced hind paw edema in rats. Sodium salicylate (300 mg/kg, i.p., SS) injection was used as a positive control drug and compared with methanolic extract of U. pilulifera (20 mg/kg; i.p.) (MUP), three different doses of aqueous extract of U. pilulifera (20, 40 and 80 mg/kg; i.p.) (AUP) and a group of distilled water (6 mL/kg; i.p.). As acute anti-inflammatory effect, AUP in doses 40 and 80 mg/kg decreased edema significantly (p<0.05). In chronic anti-inflammatory response, results indicated that all AUP doses had anti-inflammatory effects (p <0.05) with no significant difference with SS group. In conclusion, AUP had anti-inflammatory effects on both acute and chronic edema; while MUP was only effective in chronic inflammation.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43420924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Lost Ethnic Borders in Ethnopharmacological Research","authors":"Abdolali Mohagheghzade, Ehsan Amiri-Ardekani","doi":"10.18502/tim.v8i2.13076","DOIUrl":"https://doi.org/10.18502/tim.v8i2.13076","url":null,"abstract":"he Article Abstract is not available.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47905440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. Pezeshki, Hossein Pourmontaseri, M. S. Rahimabadi, Elham Haghjoo, Mohadeseh Ostovar, A. Dehghan, E. Zarenezhad, Mahsa Rostami Chijan
Type 2 diabetes (T2DM) and its complications can cause severe morbidity and mortality. The researchers and clinicians’ attention has been toward finding an efficient treatment for T2DM to decrease its heavy burden on the people and countries. Whey protein (WP) is a known glucose-lowering treatment of traditional Persian medicine. This randomized controlled clinical trial aimed to evaluate the efficacy of the WP on the improvement of the glycemic index of the patients with T2DM in Fars, Fasa, Iran. A total of 58 patients with T2DM met the inclusion criteria and were randomly assigned to one of two groups: intervention or placebo. For 12 weeks, they were given 1 sachet of WP or 1 sachet of placebo. Before and after the trial, fasting blood sugar (FBS), lipid profile, and liver enzymes were tested. Finally, 35 patients completed the study (18 in the whey group and 17 in the placebo group). The mean ± standard deviation of age, BMI, and the disease duration in placebo group were 52.1±9.2 years, 26.8±3.9 kg/m2 and 102.9±67.7 months and in WP group were 51.2±8.2 years, 25.7±3.7 kg/m2 and 74.2±51.1 months. There were no significant differences among the study groups at the beginning (P>0.05). Meanwhile, the WP and placebo groups were the same by means of the amount of anti-diabetic drugs that participants consumed (P=0.242). After 12 weeks FBS and hemoglobin A1C amounts showed remarkable decreases in the WP group compared to its starting point (P=0.011 and P=0.001 respectively); while in the placebo group, no significant difference was observed (P>0.05). No severe complications were reported in the two groups. In conclusion, we found that whey protein would be a promising complementary therapy to control hyperglycemia in the patients with T2DM.
{"title":"A Complementary Therapy with Whey Protein in Diabetes: A Double-Blind Randomized Controlled Clinical Trial","authors":"B. Pezeshki, Hossein Pourmontaseri, M. S. Rahimabadi, Elham Haghjoo, Mohadeseh Ostovar, A. Dehghan, E. Zarenezhad, Mahsa Rostami Chijan","doi":"10.18502/tim.v8i2.13081","DOIUrl":"https://doi.org/10.18502/tim.v8i2.13081","url":null,"abstract":"Type 2 diabetes (T2DM) and its complications can cause severe morbidity and mortality. The researchers and clinicians’ attention has been toward finding an efficient treatment for T2DM to decrease its heavy burden on the people and countries. Whey protein (WP) is a known glucose-lowering treatment of traditional Persian medicine. This randomized controlled clinical trial aimed to evaluate the efficacy of the WP on the improvement of the glycemic index of the patients with T2DM in Fars, Fasa, Iran. A total of 58 patients with T2DM met the inclusion criteria and were randomly assigned to one of two groups: intervention or placebo. For 12 weeks, they were given 1 sachet of WP or 1 sachet of placebo. Before and after the trial, fasting blood sugar (FBS), lipid profile, and liver enzymes were tested. Finally, 35 patients completed the study (18 in the whey group and 17 in the placebo group). The mean ± standard deviation of age, BMI, and the disease duration in placebo group were 52.1±9.2 years, 26.8±3.9 kg/m2 and 102.9±67.7 months and in WP group were 51.2±8.2 years, 25.7±3.7 kg/m2 and 74.2±51.1 months. There were no significant differences among the study groups at the beginning (P>0.05). Meanwhile, the WP and placebo groups were the same by means of the amount of anti-diabetic drugs that participants consumed (P=0.242). After 12 weeks FBS and hemoglobin A1C amounts showed remarkable decreases in the WP group compared to its starting point (P=0.011 and P=0.001 respectively); while in the placebo group, no significant difference was observed (P>0.05). No severe complications were reported in the two groups. In conclusion, we found that whey protein would be a promising complementary therapy to control hyperglycemia in the patients with T2DM.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47127627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Zali, Majid Dadmehr, M. Bahrami, A. Ghobadi, M. Kashanian, E. Akhtari
Trachyspermum ammi (L.) Sprague (commonly known as ajwain) contains ingredients that attenuate menstrual problems, especially cramping. In this study, we evaluated the impact of ajwain on the pain intensity in a sample of Iranian female college students with primary dysmenorrhea (PD) in comparison to mefenamic acid (MFA). This study was an open-label, randomized, parallel-group clinical trial conducted in the university dormitories in Tehran, Iran, from September 2018 to May 2019. Seventy patients were randomly assigned to two groups of ajwain and MFA. The participants in the ajwain group were treated with a 500 mg ajwain capsule three times a day for seven days, from the 26th cycle day to the 3rd day of the menstrual cycle, for three consecutive cycle periods. The other group received MFA capsules with the first dose of 500 mg and then 250 mg every eight hours, if necessary, from the first day of the menstrual cycle. The two groups were compared in terms of the pain intensity by the visual analog scale (VAS) in pre-intervention cycle and three consecutive cycles during the study. Maximum pain intensity, mean pain, and duration of pain after the intervention were significantly reduced in both groups. The mean VAS score significantly decreased in the ajwain group compared to the MFA group post-intervention (p < 0.02). Moreover, passing blood clots was significantly reduced in the ajwain group (p < 0.03). The findings of this study suggest that ajwain may be effective in pain relief in PD without adverse effects.
{"title":"A Comparison of the Effect of Ajwain (Trachyspermum ammi (L.) Sprague) and Mefenamic Acid for Alleviating the Symptoms of Primary Dysmenorrhea: An Open-Label Randomized Controlled Trial","authors":"F. Zali, Majid Dadmehr, M. Bahrami, A. Ghobadi, M. Kashanian, E. Akhtari","doi":"10.18502/tim.v8i2.13078","DOIUrl":"https://doi.org/10.18502/tim.v8i2.13078","url":null,"abstract":"Trachyspermum ammi (L.) Sprague (commonly known as ajwain) contains ingredients that attenuate menstrual problems, especially cramping. In this study, we evaluated the impact of ajwain on the pain intensity in a sample of Iranian female college students with primary dysmenorrhea (PD) in comparison to mefenamic acid (MFA). This study was an open-label, randomized, parallel-group clinical trial conducted in the university dormitories in Tehran, Iran, from September 2018 to May 2019. Seventy patients were randomly assigned to two groups of ajwain and MFA. The participants in the ajwain group were treated with a 500 mg ajwain capsule three times a day for seven days, from the 26th cycle day to the 3rd day of the menstrual cycle, for three consecutive cycle periods. The other group received MFA capsules with the first dose of 500 mg and then 250 mg every eight hours, if necessary, from the first day of the menstrual cycle. The two groups were compared in terms of the pain intensity by the visual analog scale (VAS) in pre-intervention cycle and three consecutive cycles during the study. Maximum pain intensity, mean pain, and duration of pain after the intervention were significantly reduced in both groups. The mean VAS score significantly decreased in the ajwain group compared to the MFA group post-intervention (p < 0.02). Moreover, passing blood clots was significantly reduced in the ajwain group (p < 0.03). The findings of this study suggest that ajwain may be effective in pain relief in PD without adverse effects.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49215700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Foeniculum vulgare Mill. (F. vulgare) belongs to the family Apiaceae with numerous medicinal and traditional applications. It has been widely used in South Asia as an important ayurvedic medicine for the treatment of many ailments. This plant of F. vulgare, including the seeds, leaves, aerial part and fruits, has been found to contain diverse phytochemicals, including anethole, fenchone, limonene, estragole, and p-coumaric acid with various bioactivities. In particular, anethole and fenchone as the chief bioactives isolated from F. vulgare, have been proven to possess notable antioxidant, antitumor, carminative, diuretic, and galactagogue effects and is useful in amenorrhoea, dental decay and irritable bowel syndrome. This review summarizes the botanical activitis, traditional uses, phytochemistry, and pharmacology of F. vulgare, along with the clinical studies to serve as the basis for further research and development on this medicinal plant.
{"title":"Foeniculum vulgare Mill. from Spice to Pharma: Recent Advances in Its Medicinal Value, Bioactivities, and Perspectives","authors":"Shilpa Debnath, Hardik Kumar, Alok Sharma","doi":"10.18502/tim.v8i2.13087","DOIUrl":"https://doi.org/10.18502/tim.v8i2.13087","url":null,"abstract":"Foeniculum vulgare Mill. (F. vulgare) belongs to the family Apiaceae with numerous medicinal and traditional applications. It has been widely used in South Asia as an important ayurvedic medicine for the treatment of many ailments. This plant of F. vulgare, including the seeds, leaves, aerial part and fruits, has been found to contain diverse phytochemicals, including anethole, fenchone, limonene, estragole, and p-coumaric acid with various bioactivities. In particular, anethole and fenchone as the chief bioactives isolated from F. vulgare, have been proven to possess notable antioxidant, antitumor, carminative, diuretic, and galactagogue effects and is useful in amenorrhoea, dental decay and irritable bowel syndrome. This review summarizes the botanical activitis, traditional uses, phytochemistry, and pharmacology of F. vulgare, along with the clinical studies to serve as the basis for further research and development on this medicinal plant.","PeriodicalId":52659,"journal":{"name":"Traditional and Integrative Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68136549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：